HER1-specific tumor targeting was observed in all three xenograft tumor models evaluated (Figs. 1, 2, and Table 2) supporting the hypothesis that HER1 targeting can be used for imaging and radionuclide therapy of MM. The gene discussed is EGFR; the disease is Miyoshi myopathy.